These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 1673879

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.
    Hawkins PN, Wootton R, Pepys MB.
    J Clin Invest; 1990 Dec; 86(6):1862-9. PubMed ID: 2254450
    [Abstract] [Full Text] [Related]

  • 3. Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits.
    Usui I, Kawano H, Ito S, Hamada Y, Ishihara T, Maeda S.
    Amyloid; 2001 Jun; 8(2):101-4. PubMed ID: 11409030
    [Abstract] [Full Text] [Related]

  • 4. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
    Jager PL, Hazenberg BP, Franssen EJ, Limburg PC, van Rijswijk MH, Piers DA.
    J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
    [Abstract] [Full Text] [Related]

  • 5. Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.
    Baltz ML, Caspi D, Evans DJ, Rowe IF, Hind CR, Pepys MB.
    Clin Exp Immunol; 1986 Dec; 66(3):691-700. PubMed ID: 3568456
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
    Hazenberg BP, van Rijswijk MH, Piers DA, Lub-de Hooge MN, Vellenga E, Haagsma EB, Hawkins PN, Jager PL.
    Am J Med; 2006 Apr; 119(4):355.e15-24. PubMed ID: 16564782
    [Abstract] [Full Text] [Related]

  • 7. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.
    Hawkins PN, Myers MJ, Epenetos AA, Caspi D, Pepys MB.
    J Exp Med; 1988 Mar 01; 167(3):903-13. PubMed ID: 3351437
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A primed state exists in vivo following histological regression of amyloidosis.
    Hawkins PN, Pepys MB.
    Clin Exp Immunol; 1990 Aug 01; 81(2):325-8. PubMed ID: 2387095
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis.
    Hazenberg BP, van Rijswijk MH, Lub-de Hooge MN, Vellenga E, Haagsma EB, Posthumus MD, Jager PL.
    J Nucl Med; 2007 Jun 01; 48(6):865-72. PubMed ID: 17504868
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
    Hawkins PN, Lavender JP, Pepys MB.
    N Engl J Med; 1990 Aug 23; 323(8):508-13. PubMed ID: 2377176
    [Abstract] [Full Text] [Related]

  • 12. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
    Coria F, Castaño E, Prelli F, Larrondo-Lillo M, van Duinen S, Shelanski ML, Frangione B.
    Lab Invest; 1988 Apr 23; 58(4):454-8. PubMed ID: 2965774
    [Abstract] [Full Text] [Related]

  • 13. AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product.
    Westermark GT, Sletten K, Grubb A, Westermark P.
    Am J Pathol; 1990 Aug 23; 137(2):377-83. PubMed ID: 2386201
    [Abstract] [Full Text] [Related]

  • 14. Amyloid fibril protein AA. Characterization of uncommon subspecies from a patient with rheumatoid arthritis.
    Westermark GT, Westermark P, Sletten K.
    Lab Invest; 1987 Jul 23; 57(1):57-64. PubMed ID: 3298850
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.
    Tennent GA, Lovat LB, Pepys MB.
    Proc Natl Acad Sci U S A; 1995 May 09; 92(10):4299-303. PubMed ID: 7753801
    [Abstract] [Full Text] [Related]

  • 17. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo.
    Hawkins PN.
    Clin Sci (Lond); 1994 Sep 09; 87(3):289-95. PubMed ID: 7955904
    [Abstract] [Full Text] [Related]

  • 18. Studies of the structure and binding properties of hamster female protein.
    Tennent GA, Baltz ML, Osborn GD, Butler PJ, Noble GE, Hawkins PN, Pepys MB.
    Immunology; 1993 Dec 09; 80(4):645-51. PubMed ID: 7508422
    [Abstract] [Full Text] [Related]

  • 19. Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis.
    Martin EB, Williams A, Richey T, Stuckey A, Heidel RE, Kennel SJ, Wall JS.
    Sci Rep; 2016 Mar 03; 6():22695. PubMed ID: 26936002
    [Abstract] [Full Text] [Related]

  • 20. Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component.
    de Beer FC, Baltz ML, Holford S, Feinstein A, Pepys MB.
    J Exp Med; 1981 Oct 01; 154(4):1134-9. PubMed ID: 6793685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.